Vaccine and Treatment Leaders for COVID

Drug trails and the latest on remdesivir and hydroxychloroquine studies, reports of possible vaccine progress, treating COVID in the ICU, public health policy and research on how the pandemic is progressing, can we safely “re-open,” what interventions have worked, which have not, and what still needs to be done

Panelists:

1. Rachel Hess, MD, MS - Chief, Division of Health System Innovation and Research - University of Utah Health. Hess is co-leading an outpatient clinical trial. They are examining how long patients with COVID-19 shed the virus, an indication of the length of time they’re contagious, and whether hydroxychloroquine reduces shedding.


2. Nisha K. Duggal, Ph.D - Assistant Professor - Virginia Tech. Duggal is working to develop a reverse genetics system to study COVID-19 vaccines and treatments.


3. Thomas Denny, MSc, M.Phil - Professor of Medicine and Global Health - Duke University. Denny is chief operating office of the Duke Human Vaccine Institute.


4. Natasha Martin - Associate Professor, Medicine - UCSD Health. Martin is now leading the UC San Diego Return to Learn Program -- an effort to potentially test all students, faculty and staff for COVID-19 monthly.


5. Dr. Adolfo Garcia-Sastre, Ph.D.- Director of Global Health and Emerging Pathogens Institute, Professor - Mount Sinai